CFM
BSX icon

Catalyst Funds Management’s Boston Scientific BSX Stock Holding History

Catalyst Funds Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$363K Buy
+8,500
New +$462K 0.02% 464
2025
Q4 		– Sell
-2,100
Closed -$205K – 363
2025
Q3 		$205K Buy
+2,100
New +$217K 0.03% 419
2024
Q4 		– Sell
-2,700
Closed -$226K – 454
2024
Q3 		$226K Buy
2,700
+2,300
+575% +$181K 0.05% 258
2024
Q2 		$30.8K Buy
+400
New +$29.3K 0.01% 549

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Catalyst Funds Management's BSX Position: Q2 2026 in Review

Catalyst Funds Management opened a new position in Boston Scientific (BSX) in Q2 2026: 8,500 shares worth $363K. The stake represents 0.02% of the portfolio and ranks #464 among its holdings. This is a return to the name: Catalyst Funds Management previously reported a position in BSX as recently as Q3 2025.

Catalyst Funds Management first reported a position in BSX in Q2 2024 and has held it in 4 quarters since. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Catalyst Funds Management held 8,500 shares of Boston Scientific worth $363K as of Q2 2026.
  • Boston Scientific was a new Catalyst Funds Management position in Q2 2026.
  • Boston Scientific made up 0.02% of Catalyst Funds Management's portfolio in Q2 2026, its #464 holding.
  • Catalyst Funds Management first reported a position in Boston Scientific in Q2 2024 and has held it in 4 quarters since.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.